MULROY DENNIS (Chief Financial Officer) received a stock award from LA JOLLA PHARMACEUTICAL CO
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/4/2020ACC: 0000920465-20-000063
Officer· Chief Financial Officer
Since Oct 2018
+106.00
Net shares
Net buyer
$327.01
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
106.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+53.00
Price / share
$6.17
Trade value
$327.01
% of position
1.1%
4/30/2020
4.88K→4.93K
Total
Net shares
+53.00
Net value
$327.01
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/30/2020 | A · Award | +53.00 | $6.17 | $327.01 | 1.1% | 4.88K | 4.93K |
| Total | +53.00 | $327.01 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
53.00 shares
Shares
+53.00
Strike price
7.26
Held after
53.00
Exercisable
—
4/30/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock53.00 shares | 4/30/2020 | A · Award | +53.00 | 7.26 | — | 53.00 |